Navigation Links
Quest PharmaTech Receives Support from National Research Council's Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer
Date:4/22/2008

EDMONTON, April 22 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") is pleased to announce that it will receive generous support from NRC-IRAP towards the development of Quest's Sonodynamic Therapy (SDT) for oncology applications.

Sonodynamic Therapy arises out of the Company's long-term interest in Hypocrellin-based photodynamic therapy for oncology and skin diseases. The Company's lead compound, SL017, with Intense Pulse Light is currently being evaluated for hair removal applications in a 90 patient Phase II clinical trial. A second product, SL052, in combination with laser light activation is in late-stage pre-clinical development for prostate cancer treatment and is scheduled to enter a Phase I clinical trial during the second half of 2008. Both products can also be activated by ultrasound.

SDT involves the administration of non-toxic pharmaceutical agents which may be activated deep within the body, by ultrasound, which is in itself non-toxic. The attractive features of this technology for cancer treatment emerges from the ability to focus the ultrasound energy on malignancy sites buried deep in tissues and to locally activate a preloaded sonosensitizer. The goal of SDT is to provide effective and specific eradication or control of tumors, while minimizing or eliminating toxicity and morbidity to the remainder of the patient.

Financial support of up to $198,362 from NRC/IRAP will help the Company to obtain proof-of-concept for the use of its proprietary Hypocrellin-based compounds for Sonodynamic Therapy applications. Technology development will also include new formulations involving nanoparticles and development of unique ultrasound transducers. In addition to the financial support, IRAP will continue to play an advisory role in acquiring complementary technologies to commercialize SDT-based products. The overall program will be coordinated by Dr. Gerald Miller, Executive Consultant to the Company and form
'/>"/>

SOURCE Quest PharmaTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
3. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
4. VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
5. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
6. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
7. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/-CytochromatodayannouncedtheappointmentofPeterM...r.UlrikSporkastheNovoA/SrepresentativeontheCompany...ixmembers. ,, "WeareverypleasedtowelcomePeterMo...rienceandguidanceasCytochromacontinuestomakeprogre...icalcompany,"statedAlanLewis,PhD,ChairmanofCytochr...
(Date:11/25/2009)...-FirstCall/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )a...dchiefexecutiveofficer,willpresentatthePiperJaffra...etailsareasfollows:,PiperJaffray21stAnnualHealthC...0p.m.EasternTime,Location:TheNewYorkPalaceHotel,Ne...et/ireye/,target=,_blank,title=,http://www.corpor...
(Date:11/24/2009)...or to also Visit Detroit , ...ia, French Ambassador for International Investment...ncy, , , , ,What: Ambassador Appia is available t...nitiatives adopted by France to further develop th...ovation and development., , ,When: Available for I...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesCana...s,adivisionofThompsonsLimitedofBlenheim,Ontario.Th...nces,currentseedsbusinessasthecompanyanticipatesth...SciencesHerbicideTolerantTraitTechnologyincornin20... ,, "Thisacquisitionbringstogethertwostrongprog...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...care Policy, SAN CARLOS, Calif., April 8, 2008 T...) have approved at-home sleep testing,for obstruct...d that,suspected sleep apnea sufferers undergo fac... continuous positive airway pressure (CPAP) treatm...attended home monitoring devices.,This decision wi...
...iotechnologies, Inc. (MBI) is pleased to announce ... at the Biodiversity Institute of Ontario,Universi...n MBI,s early,access program for the Apollo 100 ST...automated and integrated system for DNA sample pre...BI,s MOV(TM),(Microscale-On-Chip-Valve) technology...
...utics, Inc., a,privately held ophthalmic-focused b...entation of data from two Phase 3 clinical trials ... 0.05%, a topical steroid in,the treatment of post...ven,in a presentation by Michael Korenfeld, MD dur...e Surgery Annual Symposium in Chicago, Illinois., ...
Other Biology Technology:Medicare Approves in Home Sleep Apnea Testing 2Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing 2Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium 2Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium 3
(Date:11/23/2009)...NNATINew research presents strong evidence that th...oth outdoor traffic-related pollution and indoor e... one or the other exposure alone. , Environmen...ati (UC) College of Medicine have shown that child... particles and indoor endotoxin during early life ...
(Date:11/23/2009)...E, Calif. -- More than 160 participants gathered t... Keck FUTURES INITIATIVE conference. This year,s t...ists, engineers, and medical researchers to explor...urrounding the emerging field of synthetic biology...ology at Princeton University and this year,s conf...
(Date:11/23/2009)...ON, WI, November 16, 2009 -- A USDOE and USDA stud..., idle cropland, and cropland pasture could be con...nnial grasses, such as switchgrass, from which bio...tock. Economically viable production of a perennia...ies of biomass are removed annually is expected to...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Switchgrass produces biomass efficiently 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Onco 14899 1Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Onco 14899 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Onco 14899 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Onco 14899 4Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 1Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 2Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 3Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 4Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 5Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 6Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 7Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 8Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 9Shamir Optical Industry Ltd Reports Third Quarter 2009 Results 6374 10instaCare Corp Continues Turnaround Reports 58 25 Revenues Increase for First Three Quarters 6370 1instaCare Corp Continues Turnaround Reports 58 25 Revenues Increase for First Three Quarters 6370 2
... Dr. Francois Bolduc keeps more than 300,000 fruit...tes their genes and then tests their mental abilit...ike a comic book villain, but Bolduc is no mad sci...erta,s Faculty of Medicine & Dentistry, Bolduc has... called FMR1 in a fruit fly,s brain will wipe out ...
... Increasing pressures from climate change will rea...g a significant decline in the health of the plane...s in an international report issued today. , Rel...and the International Coral Reef Initiative, inter... "Status of Coral Reefs of the World: 2008" provid...
... This release is available in French . , Mont...an stunt growth and foster weight gain during pube...urnal of Clinical Endocrinology & Metabolism . Eve...m the McGill University Health Centre (MUHC) and t...ir study, vitamin D deficiency was found to cause ...
Other Biology News:'Fly guy' makes memory breakthrough 2Time running out on coral reefs as climate change becomes increasing threat 2Time running out on coral reefs as climate change becomes increasing threat 3Lack of vitamin D causes weight gain and stunts growth in girls 2
Mouse Anti-Verotoxin II (Shiga-like) A subunit (SLT-2a) Monoclonal Antibody, Unconjugated, Clone 557 from Meridian Life Science, Inc.
TSQ Quantum Discovery MAX from Thermo Scientific
BD Falcon 1536-well Black Microplates from BD Biosciences - Discovery Labware
...lates have low background fluorescence, minimal li...ed (or medium binding) polystyrene surface is hydr...assive interactions,• Is suitable primarily ... antibodies, that have large hydrophobic regions t...
Biology Products: